Ignite Creation Date:
2025-12-24 @ 7:02 PM
Ignite Modification Date:
2026-02-01 @ 5:59 AM
Study NCT ID:
NCT03000257
Status:
COMPLETED
Last Update Posted:
2022-04-14
First Post:
2016-12-15
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Study of Budigalimab (ABBV-181) in Participants With Advanced Solid Tumors
Sponsor:
AbbVie
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2016-12-14
Start Date Type:
ACTUAL
Primary Completion Date:
2022-03-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-03-29
Completion Date Type:
ACTUAL
First Submit Date:
2016-12-15
First Submit QC Date:
None
Study First Post Date:
2016-12-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-04-13
Last Update Post Date:
2022-04-14
Last Update Post Date Type:
ACTUAL